# Single Dose Study of PF-04991532 in Healthy Subjects

> **NCT01102673** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (estimated)

## Conditions studied

- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Glucose Metabolism Disorders

## Interventions

- **DRUG:** PF-04991532
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01102673
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2010-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102673, "Single Dose Study of PF-04991532 in Healthy Subjects". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01102673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*